6-K Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 Q2 2019

Filing Information

Form Type	6-K
Accession Number	`0001213900-19-018950`
Period End Date	20190630
Filing Date	20190926
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	clgn-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 64 Cash Flow Statement 70 Stockholders Equity 18

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalents`	$5.14M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$2.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$1.74M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Trade receivables	`TradeReceivables`	$611.00K	USD	Point-in-time
Trade receivables	`TradeReceivables`	$516.00K	USD	Point-in-time
Other	`OtherCurrentReceivables`	$334.00K	USD	Point-in-time
Other	`OtherCurrentReceivables`	$294.00K	USD	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	$154.00K	USD	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	$11.00K	USD	Point-in-time
Inventory	`Inventories`	$814.00K	USD	Point-in-time
Inventory	`Inventories`	$958.00K	USD	Point-in-time
Total current assets	`CurrentAssets`	$7.17M	USD	Point-in-time
Total current assets	`CurrentAssets`	$3.61M	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$163.00K	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$155.00K	USD	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	$18.00K	USD	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	-	USD	Point-in-time
Right-of-use assets	`RightofuseAssets`	$3.47M	USD	Point-in-time
Right-of-use assets	`RightofuseAssets`	$3.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$1.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$2.24M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	$340.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	$316.00K	USD	Point-in-time
Total non-current assets	`NoncurrentAssets`	$5.93M	USD	Point-in-time
Total non-current assets	`NoncurrentAssets`	$1.92M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.09M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.55M	USD	Point-in-time
Loan	`LongTermLoanCurrent`	$18.00K	USD	Point-in-time
Loan	`LongTermLoanCurrent`	$22.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$761.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$622.00K	USD	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$679.00K	USD	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$631.00K	USD	Point-in-time
Lease liabilities	`CurrentLeaseLiabilities`	$604.00K	USD	Point-in-time
Lease liabilities	`CurrentLeaseLiabilities`	$484.00K	USD	Point-in-time
Contract liabilities	`CurrentContractLiabilities`	$970.00K	USD	Point-in-time
Contract liabilities	`CurrentContractLiabilities`	$1.24M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$2.25M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$3.30M	USD	Point-in-time
Warrants at fair value	`WarrantsAtFairValue`	$573.00K	USD	Point-in-time
Warrants at fair value	`WarrantsAtFairValue`	$649.00K	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$97.00K	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$327.00K	USD	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	$316.00K	USD	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	$196.00K	USD	Point-in-time
Loan	`LongTermLoanNonCurrent`	$22.00K	USD	Point-in-time
Loan	`LongTermLoanNonCurrent`	$18.00K	USD	Point-in-time
Lease liabilities	`NoncurrentLeaseLiabilities`	$3.01M	USD	Point-in-time
Lease liabilities	`NoncurrentLeaseLiabilities`	$3.00M	USD	Point-in-time
Contract liabilities	`NoncurrentContractLiabilities`	$304.00K	USD	Point-in-time
Contract liabilities	`NoncurrentContractLiabilities`	$980.00K	USD	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$4.42M	USD	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$2.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.72M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	USD	Point-in-time
Ordinary shares	`OrdinaryShares`	$1.58M	USD	Point-in-time
Ordinary shares	`OrdinaryShares`	$1.58M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$54.76M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$54.76M	USD	Point-in-time
Currency translation differences	`ReserveOfExchangeDifferencesOnTranslation`	$-1.01M	USD	Point-in-time
Currency translation differences	`ReserveOfExchangeDifferencesOnTranslation`	$-1.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-53.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-50.55M	USD	Point-in-time
TOTAL EQUITY	`Equity`	$3.54M	USD	Point-in-time
TOTAL EQUITY	`Equity`	$4.78M	USD	Point-in-time
TOTAL EQUITY	`Equity`	$2.62M	USD	Point-in-time
TOTAL EQUITY	`Equity`	$1.83M	USD	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	$9.09M	USD	Point-in-time
TOTAL LIABILITIES AND EQUITY	`EquityAndLiabilities`	$9.55M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenue`	$182.00K	USD	1 Quarter
Revenue	`Revenue`	$606.00K	USD	1 Quarter
Revenue	`Revenue`	$1.20M	USD	2 Qtrs
Revenue	`Revenue`	$407.00K	USD	2 Qtrs
Cost of Revenue	`CostOfSales`	$453.00K	USD	1 Quarter
Cost of Revenue	`CostOfSales`	$67.00K	USD	1 Quarter
Cost of Revenue	`CostOfSales`	$858.00K	USD	2 Qtrs
Cost of Revenue	`CostOfSales`	$92.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$342.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$115.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$153.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$315.00K	USD	2 Qtrs
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	$641.00K	USD	1 Quarter
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	$797.00K	USD	1 Quarter
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	$1.93M	USD	2 Qtrs
Research and development expenses, net:	`ResearchAndDevelopmentExpense`	$1.67M	USD	2 Qtrs
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$1.81M	USD	2 Qtrs
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$1.86M	USD	2 Qtrs
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$944.00K	USD	1 Quarter
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$863.00K	USD	1 Quarter
Total operating costs and expenses:	`OperatingExpense`	$1.74M	USD	1 Quarter
Total operating costs and expenses:	`OperatingExpense`	$3.49M	USD	2 Qtrs
Total operating costs and expenses:	`OperatingExpense`	$1.50M	USD	1 Quarter
Total operating costs and expenses:	`OperatingExpense`	$3.79M	USD	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	$-1.59M	USD	1 Quarter
Operating loss	`ProfitLossFromOperatingActivities`	$-3.14M	USD	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	$-3.48M	USD	2 Qtrs
Operating loss	`ProfitLossFromOperatingActivities`	$-1.39M	USD	1 Quarter
Financial income	`FinanceIncome`	$25.00K	USD	2 Qtrs
Financial income	`FinanceIncome`	$47.00K	USD	1 Quarter
Financial income	`FinanceIncome`	$325.00K	USD	1 Quarter
Financial income	`FinanceIncome`	-	USD	2 Qtrs
Financial expenses	`FinanceCosts`	$247.00K	USD	1 Quarter
Financial expenses	`FinanceCosts`	$64.00K	USD	1 Quarter
Financial expenses	`FinanceCosts`	$237.00K	USD	2 Qtrs
Financial expenses	`FinanceCosts`	$180.00K	USD	2 Qtrs
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$40.00K	USD	1 Quarter
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$-177.00K	USD	2 Qtrs
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$-193.00K	USD	1 Quarter
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$-11.00K	USD	2 Qtrs
Financial expenses (income), net	`FinanceIncomeCost`	$-160.00K	USD	1 Quarter
Financial expenses (income), net	`FinanceIncomeCost`	$-414.00K	USD	2 Qtrs
Financial expenses (income), net	`FinanceIncomeCost`	$68.00K	USD	1 Quarter
Financial expenses (income), net	`FinanceIncomeCost`	$-166.00K	USD	2 Qtrs
Loss for the period	`ProfitLoss`	$-3.64M	USD	2 Qtrs
Loss for the period	`ProfitLoss`	$-1.52M	USD	1 Quarter
Loss for the period	`ProfitLoss`	$-1.55M	USD	1 Quarter
Loss for the period	`ProfitLoss`	$-3.56M	USD	2 Qtrs
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	-	USD	2 Qtrs
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	-	USD	1 Quarter
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	$-313.00K	USD	2 Qtrs
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	$-170.00K	USD	1 Quarter
Total comprehensive loss for the period	`ComprehensiveIncome`	$-3.56M	USD	2 Qtrs
Total comprehensive loss for the period	`ComprehensiveIncome`	$-3.96M	USD	2 Qtrs
Total comprehensive loss for the period	`ComprehensiveIncome`	$-1.52M	USD	1 Quarter
Total comprehensive loss for the period	`ComprehensiveIncome`	$-1.72M	USD	1 Quarter
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$0.33	USD	1 Quarter
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$0.88	USD	2 Qtrs
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$0.36	USD	1 Quarter
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$0.76	USD	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageShares`	4.14M	shares	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageShares`	4.66M	shares	1 Quarter
Weighted average ordinary shares outstanding	`WeightedAverageShares`	4.66M	shares	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageShares`	4.35M	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Loss for the period	`ProfitLoss`	$-3.64M	USD	2 Qtrs
Loss for the period	`ProfitLoss`	$-1.52M	USD	1 Quarter
Loss for the period	`ProfitLoss`	$-1.55M	USD	1 Quarter
Loss for the period	`ProfitLoss`	$-3.56M	USD	2 Qtrs
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$155.00K	USD	2 Qtrs
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$541.00K	USD	2 Qtrs
Share-based compensation to employees, directors and consultants	`AdjustmentsForSharebasedPayments`	$596.00K	USD	2 Qtrs
Share-based compensation to employees, directors and consultants	`AdjustmentsForSharebasedPayments`	$607.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`AdjustmentForExchangeDifferencesOnCashAndCashEquivalents`	$-17.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`AdjustmentForExchangeDifferencesOnCashAndCashEquivalents`	$-44.00K	USD	2 Qtrs
Change in fair value of financial instruments	`AdjustmentsForFairValueGainsLosses`	$154.00K	USD	2 Qtrs
Change in fair value of financial instruments	`AdjustmentsForFairValueGainsLosses`	$725.00K	USD	2 Qtrs
Exchange differences on lease liabilities	`AdjustmentsForExchangeDifferencesOnLeaseLiabilities`	$298.00K	USD	2 Qtrs
Exchange differences on lease liabilities	`AdjustmentsForExchangeDifferencesOnLeaseLiabilities`	-	USD	2 Qtrs
Exchange differences on restricted cash	`AdjustmentsForExchangeDifferencesOnRestrictedCash`	-	USD	2 Qtrs
Exchange differences on restricted cash	`AdjustmentsForExchangeDifferencesOnRestrictedCash`	$-10.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsForReconcileProfitLoss`	$-2.02M	USD	2 Qtrs
Total adjustments	`AdjustmentsForReconcileProfitLoss`	$-2.17M	USD	2 Qtrs
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-338.00K	USD	2 Qtrs
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-95.00K	USD	2 Qtrs
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-467.00K	USD	2 Qtrs
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-144.00K	USD	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables`	$-55.00K	USD	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables`	$36.00K	USD	2 Qtrs
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentsForIncreaseDecreaseInTradeAccountPayable`	$-144.00K	USD	2 Qtrs
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentsForIncreaseDecreaseInTradeAccountPayable`	$122.00K	USD	2 Qtrs
Increase (decrease) in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInOtherOperatingPayables`	$91.00K	USD	2 Qtrs
Increase (decrease) in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInOtherOperatingPayables`	$-127.00K	USD	2 Qtrs
Decrease in contract liabilities (including long-term contract liabilities)	`AdjustmentsForIncreaseDecreaseInContractLiabilitiesIncludingLongtermContractLiabilities`	-	USD	2 Qtrs
Decrease in contract liabilities (including long-term contract liabilities)	`AdjustmentsForIncreaseDecreaseInContractLiabilitiesIncludingLongtermContractLiabilities`	$-411.00K	USD	2 Qtrs
Decrease in royalties to the IIA, including short term royalties	`AdjustmentsForIncreaseDecreaseInRoyaltiesToIiaIncludingShortTermRoyalties`	$-118.00K	USD	2 Qtrs
Decrease in royalties to the IIA, including short term royalties	`AdjustmentsForIncreaseDecreaseInRoyaltiesToIiaIncludingShortTermRoyalties`	$-32.00K	USD	2 Qtrs
Total changes in operating asset and liability	`AdjustmentsForChangesInOperatingAssetAndLiability`	$-519.00K	USD	2 Qtrs
Total changes in operating asset and liability	`AdjustmentsForChangesInOperatingAssetAndLiability`	$-1.16M	USD	2 Qtrs
Net cash used in operating activities	`CashFlowsFromUsedInOperations`	$-3.33M	USD	2 Qtrs
Net cash used in operating activities	`CashFlowsFromUsedInOperations`	$-2.54M	USD	2 Qtrs
Restricted deposits	`ProceedsFromRestrictedDepositsClassifiedAsInvestingActivities`	$145.00K	USD	2 Qtrs
Restricted deposits	`ProceedsFromRestrictedDepositsClassifiedAsInvestingActivities`	-	USD	2 Qtrs
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$1.09M	USD	2 Qtrs
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$646.00K	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	-	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$30.00K	USD	2 Qtrs
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-646.00K	USD	2 Qtrs
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-915.00K	USD	2 Qtrs
Proceeds from issuance of shares and warrants, less issuance expenses	`ProceedsFromIssuingShares`	$1.51M	USD	2 Qtrs
Proceeds from issuance of shares and warrants, less issuance expenses	`ProceedsFromIssuingShares`	-	USD	2 Qtrs
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	-	USD	2 Qtrs
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	$60.00K	USD	2 Qtrs
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	$8.00K	USD	2 Qtrs
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	-	USD	2 Qtrs
Principal elements of lease payments	`PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities`	$36.00K	USD	2 Qtrs
Principal elements of lease payments	`PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities`	$200.00K	USD	2 Qtrs
Exercise of options into shares	`ProceedsFromExerciseOfOptions`	-	USD	2 Qtrs
Exercise of options into shares	`ProceedsFromExerciseOfOptions`	$7.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`CashFlowsFromUsedInFinancingActivities`	$1.53M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`CashFlowsFromUsedInFinancingActivities`	$-201.00K	USD	2 Qtrs
Decrease in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	$-3.66M	USD	2 Qtrs
Decrease in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	$-2.45M	USD	2 Qtrs
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$5.14M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$2.56M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$1.74M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Impact of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$44.00K	USD	2 Qtrs
Impact of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$-126.00K	USD	2 Qtrs
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$5.14M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$2.56M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$1.74M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Conversion of debentures and pre-paid warrants	`ConversionOfDebenturesAndPrepaidWarrants`	-	USD	2 Qtrs
Conversion of debentures and pre-paid warrants	`ConversionOfDebenturesAndPrepaidWarrants`	$3.74M	USD	2 Qtrs

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Net of issuance expenses	`NetOfIssuanceExpenses`	$96.00K	USD	2 Qtrs
BALANCE	`Equity`	$3.54M	USD	Point-in-time
BALANCE	`Equity`	$4.78M	USD	Point-in-time
BALANCE	`Equity`	$2.62M	USD	Point-in-time
BALANCE	`Equity`	$1.83M	USD	Point-in-time
Comprehensive loss	`ComprehensiveIncome`	$-3.56M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncome`	$-3.96M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncome`	$-1.52M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncome`	$-1.72M	USD	1 Quarter
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$596.00K	USD	2 Qtrs
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$607.00K	USD	2 Qtrs
Exercise of option into shares	`IncreaseDecreaseThroughExerciseOfOptions`	$7.00K	USD	2 Qtrs
Conversion of debentures to prepaid warrants	`IncreaseDecreaseThroughConversionOfConvertibleInstruments`	$3.74M	USD	2 Qtrs
Issue of shares, net of issuance expenses of $96 thousand	`ShareIssueRelatedCost`	$532.00K	USD	2 Qtrs
BALANCE	`Equity`	$3.54M	USD	Point-in-time
BALANCE	`Equity`	$4.78M	USD	Point-in-time
BALANCE	`Equity`	$2.62M	USD	Point-in-time
BALANCE	`Equity`	$1.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.